GUCY1A1 Antikörper (N-Term)
Kurzübersicht für GUCY1A1 Antikörper (N-Term) (ABIN391201)
Target
Alle GUCY1A1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 269-300, N-Term
-
Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogen
- This Guanylyl Cyclase alpha 1 (GUCY1A3) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 269-300 amino acids from the N-terminal region of human Guanylyl Cyclase alpha 1 (GUCY1A3).
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:10~50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Haltbarkeit
- 6 months
-
-
-
: "Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection." in: Brain : a journal of neurology, Vol. 133, Issue Pt 8, pp. 2313-30, (2010) (PubMed).
-
-
- GUCY1A1 (Guanylate Cyclase 1 Soluble Subunit Alpha (GUCY1A1))
-
Andere Bezeichnung
- Guanylyl Cyclase alpha 1 (GUCY1A3)
-
Hintergrund
- Soluble guanylate cyclase (sGC), a heterodimeric protein consisting of an alpha and a beta subunit, catalyzes the conversion of GTP to the second messenger cGMP and functions as the main receptor for nitric oxide and nitrovasodilator drugs.
-
Molekulargewicht
- 77452
-
Gen-ID
- 2982
-
NCBI Accession
- NP_000847, NP_001124154, NP_001124155, NP_001124156, NP_001124159, NP_001243378
-
UniProt
- Q02108
-
Pathways
- Myometrial Relaxation and Contraction
Target
-